A “new INCI” is not one global project. China wants No. 59. The EU wants an annex path or a documented history. The US wants safety substantiation and a listing that matches the label.
2023/1545 is a labeling expansion with 2026/2028 dates. It is not a same-day ban on perfume.
From 31 July 2026, new EU placements must disclose the expanded Annex III fragrance allergens. Existing stock can sell through to 31 July 2028.
Five things that actually moved a calendar in Q2: SCCS triage, China method packs, mercury date approaching, FDA Voices, leftover MoCRA rules.
NMPA replaced the 2021 new-ingredient dossier rule. If you are mid-NCI, read No. 59 before the next submission.
When Japan designates a substance as a CSCL Class I Specified Chemical, the Standards for Cosmetics already forbid it. 2026 PFAS-family designations are a formula screen, not a new cosmetics act.
Three ingredient standards enter STSC. Mercury and its compounds apply 1 July 2026 — do not mix that date with the 2028 pair.
A 30-minute read: who asked, is it in force, what date is real, what SKUs match, what you tell sales today.
An SCCS opinion is scientific advice to the Commission. It is not an annex amendment. Triage: listed in CosIng annex already, or still only an opinion?
ACSB annex updates only become “your problem” when a Member State issues a circular. Budget ten front doors, not one ASEAN certificate.